CN Patent

CN102858325A — 包含非诺贝特酸和碱化剂的口服药物组合物

Assigned to Hanmi Holdings Co Ltd · Expires 2013-01-02 · 13y expired

What this patent protects

本发明的口服药物组合物包含非诺贝特酸或其可药用盐，以及基于按重量计1份非诺贝特酸的按重量计0.22至1份的碱化剂，其具有提高的生物利用度和在胃肠道中最小化的吸收偏差，可用于治疗高脂血症和高甘油三酯血症。

USPTO Abstract

本发明的口服药物组合物包含非诺贝特酸或其可药用盐，以及基于按重量计1份非诺贝特酸的按重量计0.22至1份的碱化剂，其具有提高的生物利用度和在胃肠道中最小化的吸收偏差，可用于治疗高脂血症和高甘油三酯血症。

Drugs covered by this patent

Patent Metadata

Patent number
CN102858325A
Jurisdiction
CN
Classification
—
Expires
2013-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Hanmi Holdings Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.